Long term toxicities in women with early stage breast cancer treated with aromatase inhibitors: Data from a tertiary care center.

被引:0
|
作者
Dent, S. [1 ]
DiValentin, T. [1 ]
Vandermeer, L. [1 ]
Spaans, J. [1 ]
Verma, S. [1 ]
机构
[1] TOHRCC, Ottawa, ON, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S190 / S191
页数:2
相关论文
共 50 条
  • [1] Aromatase inhibitors and bone health in women 75 and older treated for early stage breast cancer
    Baer, L.
    Chaudhry, B.
    Kudelka, A.
    Cohen, J.
    Stopeck, A. T.
    CANCER RESEARCH, 2019, 79 (04)
  • [2] Bone Density Screening in Postmenopausal Women With Early-Stage Breast Cancer Treated With Aromatase Inhibitors
    Stratton, Jamie
    Hu, Xin
    Soulos, Pamela R.
    Davidoff, Amy J.
    Pusztai, Lajos
    Gross, Cary P.
    Mougalian, Sarah S.
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (05) : E505 - E515
  • [3] Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early stage breast cancer
    Ligibel, Jennifer A.
    Winer, Eric P.
    WOMENS HEALTH, 2006, 2 (01) : 89 - 97
  • [4] From Theory to Practice: Bone Health in Women with Early Breast Cancer Treated with Aromatase Inhibitors
    de Matos, Leonor Vasconcelos
    Fernandes, Leonor
    Neves, Maria Teresa
    Alves, Fatima
    Baleiras, Mafalda
    Ferreira, Andre
    Cotovio, Pedro Giesteira
    Domingues, Tiago Dias
    Malheiro, Mariana
    Placido, Ana
    Miranda, Maria Helena
    Martins, Ana
    CURRENT ONCOLOGY, 2021, 28 (02) : 1067 - 1076
  • [5] Systematic Review of Bone Health in Older Women Treated with Aromatase Inhibitors for Early-Stage Breast Cancer
    Becker, Taryn
    Lipscombe, Lorraine
    Narod, Steven
    Simmons, Christine
    Anderson, Geoffrey M.
    Rochon, Paula A.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2012, 60 (09) : 1761 - 1767
  • [6] Aromatase Inhibitors and Nonalcoholic Fatty Liver Disease in Early Stage Breast Cancer Women
    Lee, Kwan Sik
    Lee, Jung il
    Lee, Hyun Woong
    Chang, Hye Young
    HEPATOLOGY, 2018, 68 : 969A - 970A
  • [7] BONE LOSS IN WOMEN WITH BREAST CANCER TREATED WITH AROMATASE INHIBITORS
    Zodelava, M.
    Tsikhiseli, G.
    Nijaradze, S.
    Tskhovrebashvili, N.
    Tatishvili, N.
    Tskhovrebashvili, M.
    Mamaladze, T.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S465 - S465
  • [8] Aromatase inhibitors and calcium absorption in early stage breast cancer
    Amye Tevaarwerk
    Mark E. Burkard
    Kari B. Wisinski
    Martin M. Shafer
    Lisa A. Davis
    Jyothi Gogineni
    Elizabeth Crone
    Karen E. Hansen
    Breast Cancer Research and Treatment, 2012, 134 : 245 - 251
  • [9] Aromatase inhibitors and calcium absorption in early stage breast cancer
    Tevaarwerk, Amye
    Burkard, Mark E.
    Wisinski, Kari B.
    Shafer, Martin M.
    Davis, Lisa A.
    Gogineni, Jyothi
    Crone, Elizabeth
    Hansen, Karen E.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (01) : 245 - 251
  • [10] Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors
    Henry, N. Lynn
    Giles, Jon T.
    Ang, Dennis
    Mohan, Monika
    Dadabhoy, Dina
    Robarge, Jason
    Hayden, Jill
    Lemler, Suzanne
    Shahverdi, Karineh
    Powers, Penny
    Li, Lang
    Flockhart, David
    Stearns, Vered
    Hayes, Daniel F.
    Storniolo, Anna Maria
    Clauw, Daniel J.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 111 (02) : 365 - 372